Medical Imaging AI Platform

INTRODUCING

DEEP:PHI Key Features 

- Data Anonymization
- Strong Built-in Annotation Tools   
- PACS compatible 
- Deep Learning Features for Custom Solutions   
- Generative AI Solutions Provided

3D Scans

INSIDE DEEP:PHI

DEEP:PHI AI solutions provide medical imaging services with high performance. With DEEP:PACS, we offer a secure environment for safe and efficient medical data utilization.

DEEPNOID TEAM

T. G. KIM

CTO

AI Project Manager and Marketing

ROXIA Co.,LTD CTO

Y.T. SHIM

COO

Master Degree of Electrical

Computer Engineering

Yonsei University

SK Planet

H. J. SUNG

CFO

Accounting,

Sungkyunkwan University

Hyundai Oilbank

W. S. CHOI

CEO

Electronic Engineering,

Yonsei University

Samsung Telecommunications Research Institute

J. M. CHOI

CMO

MD Radiology Specialist

Chungnam National University College of Medicine

Bundang Jesaeng General Hospital

NEWS UPDATES

​[Youtube] Start-up 이리온

March 22, 2019

[YouTube] Start-up 이리온

The Thematic Start-up day Series

 

#1 Intensive Exploration of DEEP: PHI Platform

MCs : J.H Yoon (eBest Head of Research), Chiho Song(eBest Research Analyst)

Panels: WooSik Choi (Deepnoid CEO), Hyesang (Lisa) Lee (AI Researcher)

Machine Learning in Radiology - Takeaways from RSNA 2018

December 5, 2018

At the RSNA Machine Learning Showcase, several Asia-based companies were prominent. China had a strong presence with 10+ AI algorithm start-ups exhibiting (Yitu Health, InferVision, 12 Sigma, Deepwise, Curacloud, Huiyihuiying, LinkingMed, Synyi AI, etc out of ~40 China-based imaging AI start-ups according to this report), followed by Korea with three start-ups (Lunit, DeepNoid, VUNO), while Japan had one (LPixel) and was represented otherwise by large imaging equipment and software vendors. 

'Medical AI' DEEPNOID, goes IPO Promotion

October 30, 2018

Shinhan Investment Co. prepares exclusive technical listing ... Focuses on the medical image analysis solution 'DEEP: PHI.'

 

DEEPNOID, a medical AI company founded in 2008, will promote Initial Public Offering (IPO). After signing a contract with Shinhan Investment Co., DEEPNOID, which started working on the IPO, is striving to enter the KOSDAQ the following year. The main business area is medical AI, specifically creating an accurate and objective medical image reading standards by designing a solution model that helps the doctor's reading process.

+82-2-6952-6001

©2019 DEEPNOID Inc.